outperform price
chang recommend
downgrad ortho face slow
recoveri pt webinar et
downgrad share ahead
result evalu coverag univers term
resili disrupt go
detail webinar et hope
see
et webinar click link
rational potenti fallout chang patient
 hospit behavior impact zbh nt
procedur in-line peer med-tech group given
push-out elect worri two potenti
factor could impact
crisi level rise hdhp high deduct plan
worri pace recoveri specif
will consum get elect ortho done
post covid valid question
hospit perspect see tepid
environ big ticket capital-expenditure item persist
potenti weigh rosa robot sale
valuat pt equat price-to-earnings
ebitda slightli recent averag
repres upsid caus us d/g
share
could wrong ortho robot earli
adopt cycl shape recoveri
demand robot superior execut manag
huge fan bryan suki pose upsid risk
number
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
valuat methodolog base mix discount cash flow analysi rel valuat multipl
upsid faster expect return full product suppli faster expect uptak new product includ cementless
revis could drive knee sale growth upper end mid singl digit faster expect adopt rosa
competit share gain market incumb downsid greater expect invest result margin contract
delay reach full product suppli limit organ sale growth joint reconstruct slower expect custom
sale forc recept post complet suppli issu
articl articl
time dissemin april pm et
analyst luke sergott jon bristow daniel markowitz vijay kumar primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
